Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CZR
3401
CALL
DELISTED
Caesars Entertainment Corporation
CZR
| $2.19M | ﹤0.01% |
293,700
+184,500
| +169% | +$1.33M |
|
3402
WisdomTree Global ex-U.S. Quality Growth Fund
DNL
$498M
| $2.18M | ﹤0.01% |
88,744
-54,026
| -38% | -$1.32M |
|
3403
CALL
Owens Corning
OC
$11.3B
| $2.18M | ﹤0.01% |
40,900
+3,200
| +8% | +$172K |
|
|
STRP
3404
DELISTED
Straight Path Communications Inc.
STRP
| $2.18M | ﹤0.01% |
85,288
-12,246
| -13% | -$293K |
|
3405
Global X Silver Miners ETF NEW
SIL
$5.38B
| $2.18M | ﹤0.01% |
+49,077
| New | +$2.37M |
|
3406
Hormel Foods
HRL
$11.9B
| $2.18M | ﹤0.01% |
57,500
-9,990
| -15% | -$371K |
|
3407
VanEck Agribusiness ETF
MOO
$1.02B
| $2.18M | ﹤0.01% |
+43,648
| New | +$2.16M |
|
|
NTUS
3408
PUT
DELISTED
Natus Medical Inc
NTUS
| $2.18M | ﹤0.01% |
55,500
+27,900
| +101% | +$1.11M |
|
|
INVX
3409
PUT
Innovex International
INVX
$2.11B
| $2.18M | ﹤0.01% |
39,100
+20,300
| +108% | +$1.13M |
|
3410
Insteel Industries
IIIN
$590M
| $2.18M | ﹤0.01% |
60,095
-8,248
| -12% | -$278K |
|
3411
CALL
Extra Space Storage
EXR
$30.2B
| $2.18M | ﹤0.01% |
27,400
-4,500
| -14% | -$380K |
|
3412
First Trust Materials AlphaDEX Fund
FXZ
$400M
| $2.17M | ﹤0.01% |
63,598
+50,463
| +384% | +$1.72M |
|
|
ABAX
3413
DELISTED
Abaxis Inc
ABAX
| $2.17M | ﹤0.01% |
42,115
| – | – |
|
3414
Vanguard International Dividend Appreciation ETF
VIGI
$9.21B
| $2.17M | ﹤0.01% |
+38,097
| New | +$2.17M |
|
3415
MPLX
MPLX
$60.1B
| $2.17M | ﹤0.01% |
64,050
| – | – |
|
3416
CALL
Western Union
WU
$2.26B
| $2.17M | ﹤0.01% |
104,000
+51,200
| +97% | +$1.05M |
|
|
AXJL
3417
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
| $2.17M | ﹤0.01% |
+35,506
| New | +$2.14M |
|
|
CDK
3418
DELISTED
CDK Global, Inc.
CDK
| $2.16M | ﹤0.01% |
+37,718
| New | +$2.17M |
|
|
SBNY
3419
DELISTED
Signature Bank
SBNY
| $2.16M | ﹤0.01% |
+18,270
| New | +$2.2M |
|
3420
Icahn Enterprises
IEP
$4.82B
| $2.16M | ﹤0.01% |
42,788
-50,786
| -54% | -$2.68M |
|
3421
CALL
ITT
ITT
$18.1B
| $2.16M | ﹤0.01% |
60,300
+42,400
| +237% | +$1.45M |
|
|
PE
3422
CALL
DELISTED
PARSLEY ENERGY INC
PE
| $2.16M | ﹤0.01% |
64,500
-37,900
| -37% | -$1.19M |
|
3423
DigitalBridge
DBRG
$2.99B
| $2.16M | ﹤0.01% |
41,759
-35,846
| -46% | -$1.71M |
|
|
SYNT
3424
DELISTED
Syntel Inc
SYNT
| $2.16M | ﹤0.01% |
+51,549
| New | +$2.31M |
|
|
CA
3425
PUT
DELISTED
CA, Inc.
CA
| $2.16M | ﹤0.01% |
65,300
-51,500
| -44% | -$1.74M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.